Newsroom
Sorted by: Latest
-
SWISSto12 Selects DLR GSOC as Flight Dynamics Software Partner to Support Upcoming HummingSat Satellite Missions
RENENS, Switzerland--(BUSINESS WIRE)--SWISSto12, one of the world’s fastest-growing satellite and aerospace companies, today announced it has contracted the German Aerospace Center (DLR) to serve as the company’s primary flight dynamics software provider across its upcoming HummingSat GEO satellite missions. Under this agreement, GSOC will deliver capabilities that span orbit determination, propagation, manoeuvre planning and calibration, orbit events, antenna pointing, and long-term mission an...
-
European Employers Face Uncertain Outlook Amid Accelerating AI Adoption and Delayed EU Rules, Littler Survey Shows
LONDON--(BUSINESS WIRE)--Littler, the world’s largest employment and labour law practice representing management, has released its 2026 European Employer Survey Report. The survey finds European employers making workplace decisions amid regulatory uncertainty, as missed and delayed deadlines for key European Union (EU) laws collide with rapid adoption of artificial intelligence (AI) and economic pressures driving hiring pauses, layoffs and increased automation. The ninth annual survey draws on...
-
International SOS Risk Outlook 2027: Geopolitics, Extreme Weather and AI Threats Raise the Stakes for Workforce Protection
LONDON--(BUSINESS WIRE)--Rapidly Converging Risks Reveal Preparedness as a Competitive Advantage. International SOS today released its 11th annual Risk Outlook....
-
Avenzo Therapeutics Presents Positive Preliminary Results from the Phase 1 Study of AVZO-1418, a Potentially Best-in-Class EGFR/HER3 Bispecific Antibody-Drug Conjugate, at the 38th EORTC-NCI-AACR Symposium
SAN DIEGO--(BUSINESS WIRE)--Avenzo Therapeutics Presents Positive Preliminary Results from the Phase 1 Study of AVZO-1418, a Potentially Best-in-Class EGFR/HER3 Bispecific ADC...
-
19Labs Named a Priority Full-Stack Package in the American SI Exports Program, the Only Health Platform
REDWOOD CITY, Calif.--(BUSINESS WIRE)--19Labs, an American health technology company that partners with governments to bring advanced care to rural and remote communities, has been named a priority full-stack package in the American Super Intelligence (SI) Exports Program, the U.S. Department of Commerce's program for bringing trusted American AI to global markets. Its GALE platform is the only health platform among the 33 designated consortia. As a designated package, GALE receives priority go...
-
Approov Takes on Rented Device Farms and State-Linked Attackers with Cloud-Verified Mobile API Defense
EDINBURGH, Scotland & PALO ALTO, Calif.--(BUSINESS WIRE)--Fraud against mobile apps has stopped looking like bots. Attackers now rent real-looking phones by the hour, present device attestation that appears legitimate, and replay requests that were genuinely signed. Today Approov, a leader in mobile app and API security, announced Approov 2027 (Version 3.7), which detects rented device farms, ties every API request to the single device that produced it, and verifies both in the cloud."These are...
-
CAI Enters Into a Definitive Agreement with PQE Group, Expanding Global Life Sciences Reach
INDIANAPOLIS--(BUSINESS WIRE)--CAI, a professional services firm dedicated to accelerating operational readiness and excellence in life sciences and mission-critical environments, has entered into a definitive agreement with PQE Group, a global life sciences quality, compliance and validation consulting firm headquartered in Florence, Italy. The partnership will position the company to serve clients navigating complex, highly regulated environments around the world. The strategic alignment will...
-
IQM dévoile à SC26 un programme de mise à niveau de Halocene ouvrant la voie à plus de 1 000 qubits et accélérant l’intégration aux applications d’intelligence artificielle
CHICAGO--(BUSINESS WIRE)--IQM Quantum Computers (Nasdaq : IQMX), leader mondial de l’informatique quantique intégrée, a annoncé aujourd’hui un programme de mise à niveau de Halocene, sa gamme de produits de correction d’erreurs, permettant aux clients de passer du système actuel de 150 qubits à un futur système de plus de 1 000 qubits. Les clients peuvent dès aujourd’hui exécuter des charges de travail hybrides en parallèle de leurs systèmes d’intelligence artificielle (IA) et de calcul haute p...
-
Innate Pharma Presents Initial Phase 1 Clinical Data for IPH4502 at ENA 2026
MARSEILLE, France--(BUSINESS WIRE)--Innate Pharma presents initial Phase 1 clinical data for IPH4502 at ENA 2026...
-
Innate Pharma présente les premières données cliniques de Phase 1 d’IPH4502 à l’occasion du symposium ENA 2026
MARSEILLE--(BUSINESS WIRE)--Regulatory News: Innate Pharma S.A. (Euronext Paris : IPH ; Nasdaq : IPHA) (« Innate » ou la « Société ») annonce aujourd’hui la présentation des premières données de Phase 1 issues de son étude en cours évaluant IPH4502, un conjugué anticorps-médicament (ADC) expérimental ciblant Nectine-4 et intégrant une charge utile d’exatécan, chez des patients atteints de tumeurs solides avancées. Les résultats sont présentés aujourd’hui à l’occasion du 38e symposium EORTC-NCI-...